Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MMP1 | P03956 | 1/20 | 0.38 |
| ▸ | MMP9 | P14780 | 1/20 | 0.38 |
| ▸ | MMP14 | P50281 | 1/20 | 0.38 |
| ▸ | FFAR2 | O15552 | 1/20 | 0.32 |
| ▸ | POLB | P06746 | 1/20 | 0.32 |
| ▸ | CNR2 | P34972 | 1/20 | 0.32 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.31 |
| ▸ | CTSS | P25774 | 1/20 | 0.31 |
| ▸ | CTSK | P43235 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22421642 | 1.00 | MMP1 (0.38) | MMP1MMP9MMP14FFAR2POLB | |
| SCHEMBL29878045 | 1.00 | MMP1 (0.38) | MMP1MMP9MMP14FFAR2POLB | |
| SCHEMBL15033256 | 1.00 | MMP1 (0.38) | MMP1MMP9MMP14FFAR2POLB | |
| SCHEMBL19401641 | 0.91 | FFAR2 (0.36) | MMP1MMP9MMP14FFAR2 | |
| SCHEMBL13260893 | 0.91 | FFAR2 (0.36) | MMP1MMP9MMP14FFAR2 | |
| SCHEMBL14511336 | 0.91 | FFAR2 (0.36) | MMP1MMP9MMP14FFAR2 | |
| SCHEMBL17305511 | 0.84 | SMN1; SMN2 (0.42) | POLBSMN1; SMN2 | |
| SCHEMBL19201191 | 0.84 | FFAR2 (0.32) | MMP1FFAR2 | |
| SCHEMBL19201193 | 0.84 | FFAR2 (0.32) | MMP1FFAR2 | |
| SCHEMBL26789813 | 0.84 | MMP1 (0.38) | MMP1MMP9MMP14FFAR2POLB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2022079445-A1 | BICYCLIC PEPTIDE LIGAND DRUG CONJUGATES | Bicyclerd Limited (GB) | 2022-04-21 | — | — | WO | disclosed |
| US-9586978-B2 | Anti-viral compounds | ABBVIE INC. (US) | 2017-03-07 | — | — | US | disclosed |